As of 2024-12-15, the EV/EBITDA ratio of ABIOMED Inc (ABMD) is
92.71.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Abiomed's latest enterprise value
is 16,998.27 mil USD. Abiomed's TTM EBITDA according to its financial statements is
183.34 mil USD. Dividing these 2
quantities gives us the above Abiomed EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
12.2x - 35.2x |
21.8x |
| Forward P/E multiples |
18.9x - 39.7x |
29.0x |
| Fair Price |
53.73 - 200.65 |
120.27 |
| Upside |
-85.9% - -47.3% |
-68.4% |